Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 120–120 | Cite as

Eribulin/pazopanib

Various toxicities: case report
Case report
  • 9 Downloads

Reference

  1. Fujimoto E, et al. Uterine leiomyosarcoma well-controlled with eribulin mesylate. International Cancer Conference Journal 8: 33-38, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1007/s13691-018-0350-1 - JapanCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations